# Center for Fertility and Reproductive Endocrinology UPP – FDA Inspection, Jan 23, 2024

Source: https://www.keypedia.com/records/fda_inspections/center-for-fertility-and-reproductive-endocrinology-upp/ebf06c32-9819-4d2a-9d5e-fa0cfec54367
Source feed: FDA_Inspections

> FDA inspection 1228172 of Center for Fertility and Reproductive Endocrinology UPP, January 23, 2024. Classification: No Action Indicated (NAI). 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1228172
- Company Name: Center for Fertility and Reproductive Endocrinology UPP
- Inspection Date: 2024-01-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1158607 - 2021-12-08
- FDA Inspection 1069130 - 2018-08-08
- FDA Inspection 1027413 - 2017-08-29
- [FDA Inspection 972652 - 2016-05-26](https://www.keypedia.com/records/fda_inspections/center-for-fertility-and-reproductive-endocrinology-upp/b28dbcbf-671e-4b5f-8257-980c2c504932)
- FDA Inspection 937750 - 2015-08-12

## Related Officers

- [Investigator](https://www.keypedia.com/people/carl-e-lovrich/28ad3898-eaac-4f07-8dc5-09bda890c63a)

Company: https://www.keypedia.com/companies/center-for-fertility-and-reproductive-endocrinology-upp/6019ae52-373a-4b57-bc21-390f533bc8e7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
